Intrinsic value of Colgate-Palmolive - CL

Previous Close

$69.14

  Intrinsic Value

$10.05

stock screener

  Rating & Target

str. sell

-85%

Previous close

$69.14

 
Intrinsic value

$10.05

 
Up/down potential

-85%

 
Rating

str. sell

We calculate the intrinsic value of CL stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  -5.23
  2.80
  3.02
  3.22
  3.40
  3.56
  3.70
  3.83
  3.95
  4.05
  4.15
  4.23
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.63
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.82
  4.84
  4.86
  4.87
  4.88
  4.90
Revenue, $m
  15,195
  15,620
  16,092
  16,610
  17,174
  17,785
  18,443
  19,150
  19,906
  20,712
  21,572
  22,485
  23,454
  24,481
  25,568
  26,717
  27,932
  29,215
  30,569
  31,996
  33,501
  35,086
  36,756
  38,514
  40,365
  42,312
  44,361
  46,516
  48,782
  51,165
  53,671
Variable operating expenses, $m
 
  12,897
  13,280
  13,700
  14,158
  14,654
  15,189
  15,763
  16,377
  17,032
  17,730
  18,261
  19,047
  19,882
  20,764
  21,698
  22,685
  23,727
  24,826
  25,985
  27,207
  28,495
  29,851
  31,279
  32,782
  34,363
  36,027
  37,777
  39,618
  41,553
  43,588
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  11,358
  12,897
  13,280
  13,700
  14,158
  14,654
  15,189
  15,763
  16,377
  17,032
  17,730
  18,261
  19,047
  19,882
  20,764
  21,698
  22,685
  23,727
  24,826
  25,985
  27,207
  28,495
  29,851
  31,279
  32,782
  34,363
  36,027
  37,777
  39,618
  41,553
  43,588
Operating income, $m
  3,837
  2,724
  2,812
  2,910
  3,016
  3,130
  3,254
  3,387
  3,529
  3,680
  3,842
  4,224
  4,406
  4,599
  4,803
  5,019
  5,248
  5,489
  5,743
  6,011
  6,294
  6,592
  6,905
  7,236
  7,583
  7,949
  8,334
  8,739
  9,165
  9,612
  10,083
EBITDA, $m
  4,280
  3,257
  3,356
  3,464
  3,581
  3,709
  3,846
  3,993
  4,151
  4,319
  4,498
  4,689
  4,891
  5,105
  5,332
  5,572
  5,825
  6,092
  6,375
  6,672
  6,986
  7,317
  7,665
  8,032
  8,418
  8,824
  9,251
  9,700
  10,173
  10,670
  11,192
Interest expense (income), $m
  162
  228
  145
  156
  167
  180
  193
  208
  224
  241
  259
  278
  299
  320
  343
  367
  393
  420
  449
  479
  511
  545
  580
  618
  657
  698
  742
  788
  836
  886
  940
Earnings before tax, $m
  3,738
  2,496
  2,667
  2,754
  2,849
  2,951
  3,061
  3,179
  3,305
  3,440
  3,583
  3,946
  4,108
  4,279
  4,460
  4,652
  4,854
  5,068
  5,294
  5,532
  5,783
  6,047
  6,325
  6,618
  6,926
  7,251
  7,592
  7,951
  8,329
  8,726
  9,143
Tax expense, $m
  1,152
  674
  720
  744
  769
  797
  826
  858
  892
  929
  967
  1,065
  1,109
  1,155
  1,204
  1,256
  1,311
  1,368
  1,429
  1,494
  1,561
  1,633
  1,708
  1,787
  1,870
  1,958
  2,050
  2,147
  2,249
  2,356
  2,469
Net income, $m
  2,441
  1,822
  1,947
  2,011
  2,079
  2,154
  2,234
  2,320
  2,413
  2,511
  2,616
  2,881
  2,999
  3,124
  3,256
  3,396
  3,544
  3,700
  3,864
  4,038
  4,221
  4,414
  4,617
  4,831
  5,056
  5,293
  5,542
  5,804
  6,080
  6,370
  6,675

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  1,338
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  12,123
  11,086
  11,421
  11,789
  12,189
  12,622
  13,090
  13,591
  14,128
  14,700
  15,310
  15,958
  16,646
  17,374
  18,146
  18,962
  19,824
  20,735
  21,695
  22,708
  23,776
  24,902
  26,087
  27,334
  28,648
  30,030
  31,484
  33,014
  34,622
  36,313
  38,091
Adjusted assets (=assets-cash), $m
  10,785
  11,086
  11,421
  11,789
  12,189
  12,622
  13,090
  13,591
  14,128
  14,700
  15,310
  15,958
  16,646
  17,374
  18,146
  18,962
  19,824
  20,735
  21,695
  22,708
  23,776
  24,902
  26,087
  27,334
  28,648
  30,030
  31,484
  33,014
  34,622
  36,313
  38,091
Revenue / Adjusted assets
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
  1.409
Average production assets, $m
  5,148
  5,295
  5,455
  5,631
  5,822
  6,029
  6,252
  6,492
  6,748
  7,022
  7,313
  7,622
  7,951
  8,299
  8,667
  9,057
  9,469
  9,904
  10,363
  10,847
  11,357
  11,894
  12,460
  13,056
  13,684
  14,344
  15,038
  15,769
  16,537
  17,345
  18,194
Working capital, $m
  1,033
  -297
  -306
  -316
  -326
  -338
  -350
  -364
  -378
  -394
  -410
  -427
  -446
  -465
  -486
  -508
  -531
  -555
  -581
  -608
  -637
  -667
  -698
  -732
  -767
  -804
  -843
  -884
  -927
  -972
  -1,020
Total debt, $m
  6,533
  4,145
  4,446
  4,777
  5,137
  5,527
  5,948
  6,399
  6,882
  7,397
  7,946
  8,529
  9,148
  9,804
  10,498
  11,233
  12,009
  12,828
  13,693
  14,605
  15,566
  16,578
  17,645
  18,768
  19,950
  21,194
  22,503
  23,879
  25,327
  26,849
  28,449
Total liabilities, $m
  12,366
  9,978
  10,279
  10,610
  10,970
  11,360
  11,781
  12,232
  12,715
  13,230
  13,779
  14,362
  14,981
  15,637
  16,331
  17,066
  17,842
  18,661
  19,526
  20,438
  21,399
  22,411
  23,478
  24,601
  25,783
  27,027
  28,336
  29,712
  31,160
  32,682
  34,282
Total equity, $m
  -243
  1,109
  1,142
  1,179
  1,219
  1,262
  1,309
  1,359
  1,413
  1,470
  1,531
  1,596
  1,665
  1,737
  1,815
  1,896
  1,982
  2,073
  2,170
  2,271
  2,378
  2,490
  2,609
  2,733
  2,865
  3,003
  3,148
  3,301
  3,462
  3,631
  3,809
Total liabilities and equity, $m
  12,123
  11,087
  11,421
  11,789
  12,189
  12,622
  13,090
  13,591
  14,128
  14,700
  15,310
  15,958
  16,646
  17,374
  18,146
  18,962
  19,824
  20,734
  21,696
  22,709
  23,777
  24,901
  26,087
  27,334
  28,648
  30,030
  31,484
  33,013
  34,622
  36,313
  38,091
Debt-to-equity ratio
  -26.885
  3.740
  3.890
  4.050
  4.210
  4.380
  4.540
  4.710
  4.870
  5.030
  5.190
  5.340
  5.500
  5.640
  5.790
  5.920
  6.060
  6.190
  6.310
  6.430
  6.550
  6.660
  6.760
  6.870
  6.960
  7.060
  7.150
  7.230
  7.320
  7.390
  7.470
Adjusted equity ratio
  -0.145
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  2,441
  1,822
  1,947
  2,011
  2,079
  2,154
  2,234
  2,320
  2,413
  2,511
  2,616
  2,881
  2,999
  3,124
  3,256
  3,396
  3,544
  3,700
  3,864
  4,038
  4,221
  4,414
  4,617
  4,831
  5,056
  5,293
  5,542
  5,804
  6,080
  6,370
  6,675
Depreciation, amort., depletion, $m
  443
  534
  543
  554
  566
  578
  592
  607
  622
  639
  657
  465
  485
  506
  529
  552
  577
  604
  632
  661
  692
  725
  760
  796
  834
  875
  917
  962
  1,008
  1,058
  1,109
Funds from operations, $m
  3,233
  2,355
  2,491
  2,565
  2,645
  2,732
  2,826
  2,927
  3,035
  3,150
  3,272
  3,345
  3,483
  3,630
  3,784
  3,948
  4,121
  4,304
  4,496
  4,700
  4,914
  5,139
  5,377
  5,627
  5,891
  6,168
  6,459
  6,766
  7,088
  7,427
  7,784
Change in working capital, $m
  92
  -8
  -9
  -10
  -11
  -12
  -13
  -13
  -14
  -15
  -16
  -17
  -18
  -20
  -21
  -22
  -23
  -24
  -26
  -27
  -29
  -30
  -32
  -33
  -35
  -37
  -39
  -41
  -43
  -45
  -48
Cash from operations, $m
  3,141
  2,364
  2,500
  2,574
  2,656
  2,744
  2,839
  2,940
  3,049
  3,165
  3,288
  3,363
  3,502
  3,649
  3,805
  3,970
  4,144
  4,328
  4,522
  4,727
  4,942
  5,169
  5,409
  5,661
  5,926
  6,205
  6,498
  6,807
  7,131
  7,473
  7,832
Maintenance CAPEX, $m
  0
  -314
  -323
  -333
  -343
  -355
  -368
  -381
  -396
  -411
  -428
  -446
  -465
  -485
  -506
  -529
  -552
  -577
  -604
  -632
  -661
  -692
  -725
  -760
  -796
  -834
  -875
  -917
  -962
  -1,008
  -1,058
New CAPEX, $m
  -593
  -148
  -160
  -176
  -191
  -207
  -223
  -240
  -256
  -273
  -291
  -310
  -328
  -348
  -369
  -390
  -412
  -435
  -459
  -484
  -510
  -537
  -566
  -596
  -627
  -660
  -695
  -731
  -768
  -808
  -849
Cash from investing activities, $m
  -499
  -462
  -483
  -509
  -534
  -562
  -591
  -621
  -652
  -684
  -719
  -756
  -793
  -833
  -875
  -919
  -964
  -1,012
  -1,063
  -1,116
  -1,171
  -1,229
  -1,291
  -1,356
  -1,423
  -1,494
  -1,570
  -1,648
  -1,730
  -1,816
  -1,907
Free cash flow, $m
  2,642
  1,902
  2,017
  2,066
  2,121
  2,182
  2,248
  2,320
  2,397
  2,480
  2,569
  2,607
  2,709
  2,816
  2,931
  3,052
  3,180
  3,316
  3,459
  3,611
  3,771
  3,940
  4,117
  4,305
  4,502
  4,710
  4,929
  5,159
  5,402
  5,657
  5,925
Issuance/(repayment) of debt, $m
  164
  -2,375
  301
  331
  360
  390
  420
  451
  483
  515
  549
  583
  619
  656
  694
  734
  776
  819
  865
  912
  961
  1,013
  1,067
  1,123
  1,182
  1,244
  1,309
  1,377
  1,448
  1,522
  1,600
Issuance/(repurchase) of shares, $m
  -889
  855
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -725
  -1,520
  301
  331
  360
  390
  420
  451
  483
  515
  549
  583
  619
  656
  694
  734
  776
  819
  865
  912
  961
  1,013
  1,067
  1,123
  1,182
  1,244
  1,309
  1,377
  1,448
  1,522
  1,600
Total cash flow (excl. dividends), $m
  1,853
  381
  2,318
  2,397
  2,482
  2,572
  2,668
  2,771
  2,880
  2,995
  3,118
  3,191
  3,327
  3,472
  3,625
  3,786
  3,956
  4,135
  4,324
  4,523
  4,732
  4,952
  5,184
  5,428
  5,684
  5,954
  6,238
  6,536
  6,849
  7,179
  7,525
Retained Cash Flow (-), $m
  -56
  -2,677
  -33
  -37
  -40
  -43
  -47
  -50
  -54
  -57
  -61
  -65
  -69
  -73
  -77
  -82
  -86
  -91
  -96
  -101
  -107
  -113
  -119
  -125
  -131
  -138
  -145
  -153
  -161
  -169
  -178
Prev. year cash balance distribution, $m
 
  1,325
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  -970
  2,285
  2,360
  2,442
  2,529
  2,622
  2,721
  2,826
  2,938
  3,057
  3,126
  3,259
  3,399
  3,548
  3,704
  3,870
  4,044
  4,228
  4,421
  4,625
  4,840
  5,066
  5,303
  5,553
  5,816
  6,092
  6,383
  6,688
  7,010
  7,347
Discount rate, %
 
  7.50
  7.88
  8.27
  8.68
  9.12
  9.57
  10.05
  10.55
  11.08
  11.63
  12.22
  12.83
  13.47
  14.14
  14.85
  15.59
  16.37
  17.19
  18.05
  18.95
  19.90
  20.89
  21.94
  23.04
  24.19
  25.40
  26.67
  28.00
  29.40
  30.87
PV of cash for distribution, $m
 
  -903
  1,963
  1,860
  1,750
  1,635
  1,515
  1,392
  1,267
  1,141
  1,017
  880
  766
  658
  557
  464
  381
  307
  243
  189
  144
  107
  78
  55
  38
  26
  17
  11
  7
  4
  2
Current shareholders' claim on cash, %
  100
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company's oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy's Oil Soap. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

FINANCIAL RATIOS  of  Colgate-Palmolive (CL)

Valuation Ratios
P/E Ratio 25
Price to Sales 4
Price to Book -251.3
Price to Tangible Book
Price to Cash Flow 19.4
Price to Free Cash Flow 24
Growth Rates
Sales Growth Rate -5.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -14.2%
Cap. Spend. - 3 Yr. Gr. Rate -2.4%
Financial Strength
Quick Ratio 103
Current Ratio 0.1
LT Debt to Equity -2683.1%
Total Debt to Equity -2688.5%
Interest Coverage 24
Management Effectiveness
Return On Assets 21.2%
Ret/ On Assets - 3 Yr. Avg. 16.4%
Return On Total Capital 38.9%
Ret/ On T. Cap. - 3 Yr. Avg. 29.3%
Return On Equity -900.7%
Return On Equity - 3 Yr. Avg. -149.1%
Asset Turnover 1.3
Profitability Ratios
Gross Margin 60.3%
Gross Margin - 3 Yr. Avg. 59.3%
EBITDA Margin 28.6%
EBITDA Margin - 3 Yr. Avg. 24.4%
Operating Margin 25.3%
Oper. Margin - 3 Yr. Avg. 21.1%
Pre-Tax Margin 24.6%
Pre-Tax Margin - 3 Yr. Avg. 20.8%
Net Profit Margin 16.1%
Net Profit Margin - 3 Yr. Avg. 12.4%
Effective Tax Rate 30.8%
Eff/ Tax Rate - 3 Yr. Avg. 36.2%
Payout Ratio 61.8%

CL stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CL stock intrinsic value calculation we used $15195 million for the last fiscal year's total revenue generated by Colgate-Palmolive. The default revenue input number comes from 2016 income statement of Colgate-Palmolive. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CL stock valuation model: a) initial revenue growth rate of 2.8% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.5%, whose default value for CL is calculated based on our internal credit rating of Colgate-Palmolive, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Colgate-Palmolive.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CL stock the variable cost ratio is equal to 82.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for CL stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Colgate-Palmolive.

Corporate tax rate of 27% is the nominal tax rate for Colgate-Palmolive. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CL stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CL are equal to 33.9%.

Life of production assets of 16.4 years is the average useful life of capital assets used in Colgate-Palmolive operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CL is equal to -1.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $-243 million for Colgate-Palmolive - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 874.486 million for Colgate-Palmolive is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Colgate-Palmolive at the current share price and the inputted number of shares is $60.5 billion.

RELATED COMPANIES Price Int.Val. Rating
PG Procter&Gamble 80.24 66.39  sell
CHD Church&Dwight 47.94 75.18  buy
UN Unilever ADR 52.78 33.81  sell
CAW CCA Industries 3.00 0.30  str.sell
AVP Avon Products 2.71 0.33  str.sell
CLX Clorox 126.29 77.10  sell
UL Unilever ADR 51.64 33.95  sell
KMB Kimberly-Clark 111.94 10.85  str.sell

COMPANY NEWS

▶ 3 Stocks Your Children Will Brag About Someday   [Feb-21-18 12:03PM  Motley Fool]
▶ [$$] How to read the regime change at the US Federal Reserve   [Feb-14-18 10:22PM  Financial Times]
▶ Company News For Jan 29, 2018   [09:47AM  Zacks]
▶ Hate Risk? You'll Love These 3 Stocks   [Jan-28-18 11:30AM  Motley Fool]
▶ [$$] Colgates Checkup Doesnt Go Well   [Jan-26-18 11:48PM  The Wall Street Journal]
▶ [$$] Colgate's Checkup Doesn't Go Well   [01:33PM  The Wall Street Journal]
▶ Wall Street Bull After GDP Numbers   [11:30AM  GuruFocus.com]
▶ Colgate Announces 4th Quarter 2017 Results   [06:55AM  Business Wire]
▶ Procter & Gambles 2Q Sales Indicate Return to Growth Path   [Jan-24-18 05:05PM  Market Realist]
▶ A Look at Kimberly-Clarks Sales in 4Q17   [10:15AM  Market Realist]
▶ A Look at Consumer Sector Earnings This Week   [08:09AM  Market Realist]
▶ Will Kimberly-Clarks Low Valuation Attract Investors?   [Jan-19-18 07:32AM  Market Realist]
▶ 3 Heirloom Stocks to Hold Forever   [Jan-18-18 09:31PM  Motley Fool]
▶ What Could Drive Kimberly-Clarks Earnings per Share in 4Q17   [Jan-17-18 05:35PM  Market Realist]
▶ Will KMB Stock Rise on 4Q17 Earnings?   [04:02PM  Market Realist]
▶ Colgate Declares Regular Quarterly Dividend   [Jan-11-18 04:30PM  Business Wire]
▶ [$$] Norwest Sells PCA Skin to Colgate-Palmolive   [Jan-05-18 06:46PM  The Wall Street Journal]
▶ Colgate-Palmolive a Slow But Steady Dividend Aristocrat   [Dec-30-17 11:17AM  InvestorPlace]
▶ Can Colgate-Palmolives Earnings Improve in 2018?   [Dec-29-17 09:02AM  Market Realist]
▶ Jim Cramer: This Stock Market Is Simply Short of Money   [Dec-12-17 07:01PM  TheStreet.com]
▶ 4 Change Management Keys To Digital   [Dec-07-17 03:14PM  Forbes]
▶ [$$] Which Companies Excel in Financial Strength   [Dec-05-17 03:40PM  The Wall Street Journal]
▶ How PG, KMB, CL, CLX, and CHD Compare on Valuation   [Dec-01-17 09:02AM  Market Realist]
▶ Why These Safe Haven Stocks Aren't Safe   [Nov-21-17 06:00AM  Investopedia]
Financial statements of CL
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.